
PARTNERSHIPS
17 Aug 2026
The merger creates a combined diagnostics and therapeutics powerhouse spanning 70 countries.

INNOVATION
12 Aug 2026
UMass Amherst's DiffuDose matches gold-standard accuracy while personalizing dose maps in under 23 seconds.

MARKET TRENDS
7 Aug 2026
FDA clears earlier use of the radioligand therapy, widening access across PSMA-positive metastatic disease.

INVESTMENT
2 Aug 2026
The Boston biotech's Series C will fund an actinium-225 sarcoma trial and expanded manufacturing.

REGULATORY
28 Jul 2026
Proposed rules aim to speed licensing and modernize radiation protection standards for medical isotopes.

TECHNOLOGY
19 Jul 2026
Actineer's closed-loop radium-226 process tackles a supply constraint limiting alpha therapy production.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.